Fubotv earnings beat by $0.10, revenue topped estimates
Investing.com - Texas Capital Securities reiterated its Hold rating and $2.50 price target on Aemetis (NASDAQ:AMTX) following the company’s recent quarterly results. According to InvestingPro data, the company currently trades at $2.42, with analysis suggesting the stock may be undervalued despite significant operational challenges.
The firm described the release as "slightly negative" despite some positive developments, including better-than-expected dairy RNG sales volumes, the restart of sales at the India Biodiesel business, and better-than-expected cost control on both SG&A and COGS.
Texas Capital Securities noted several negatives in the report, including lower-than-expected quarterly EBITDA, biodiesel sales, and ethanol sales volumes. The firm pointed out that Aemetis operated the Keyes plant at a lower grind rate during the second quarter of 2025 to maximize margins.
The research firm emphasized that while the company delivered lower-than-expected results from the ethanol and biodiesel businesses, market attention would likely focus on commentary about the operational and environmental attribute outlook during Thursday’s earnings call.
Texas Capital Securities maintained its neutral stance on Aemetis stock with the unchanged $2.50 price target, suggesting limited upside potential based on the current business performance.
In other recent news, Aemetis, Inc. reported several significant developments. The company announced the appointment of Anjaneyulu Ganji as the Chief Financial Officer of its India subsidiary, Universal Biofuels. This follows Ganji’s previous role as Group CFO at Dodla Dairy Limited, where he managed a highly successful initial public offering. Additionally, Aemetis received approval from the California Air Resources Board for seven dairy digester pathways, set to be effective January 1, 2025. These pathways are expected to double the number of Low Carbon Fuel Standard credits generated by the digesters.
Aemetis also entered into a $27 million agreement with Centuri Holdings, Inc. to expand its biogas system, enhancing renewable natural gas production. This expansion is part of the Aemetis Biogas Central Digester Project near Modesto, California. In financial news, Ascendiant Capital raised its price target for Aemetis stock to $20, maintaining a Buy rating due to a favorable net present value analysis. Lastly, the company announced the re-election of Eric A. McAfee and Francis P. Barton to its Board of Directors during its recent Annual Meeting of Stockholders.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.